A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE) and Sjogren's Disease (SjD)

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 26, 2025

Primary Completion Date

March 31, 2029

Study Completion Date

March 31, 2029

Conditions

Dry Eye SyndromeSystemic Lupus Erythematosus

Interventions

DRUG

ABBV-319

Intravenous (IV) Infusion

Trial Locations (2)

RECRUITING

Clinical Research Of West Florida - Tampa - North Howard Avenue /ID# 275836, Tampa

RECRUITING

Dr. Ramesh Gupta /ID# 275826, Memphis